Trials / Completed
CompletedNCT00192855
Entacapone Augmentation for Schizophrenia
Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is testing the hypothesis that Entacapone added to ongoing antipsychotic treatment can be beneficial in schizophrenic patients with negative symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Entacapone | Entacapone 600mg BID |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2005-09-19
- Last updated
- 2010-08-25
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00192855. Inclusion in this directory is not an endorsement.